SG11201500574QA - CRYSTALLINE COMPLEX OF 1-CYANO-2-(4-CYCLOPROPYL-BENZYL)-4-(ß- D-GLUCOPYRANOS-1-YL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS - Google Patents
CRYSTALLINE COMPLEX OF 1-CYANO-2-(4-CYCLOPROPYL-BENZYL)-4-(ß- D-GLUCOPYRANOS-1-YL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTSInfo
- Publication number
- SG11201500574QA SG11201500574QA SG11201500574QA SG11201500574QA SG11201500574QA SG 11201500574Q A SG11201500574Q A SG 11201500574QA SG 11201500574Q A SG11201500574Q A SG 11201500574QA SG 11201500574Q A SG11201500574Q A SG 11201500574QA SG 11201500574Q A SG11201500574Q A SG 11201500574QA
- Authority
- SG
- Singapore
- Prior art keywords
- glucopyranos
- cyclopropyl
- cyano
- benzyl
- benzene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12177944 | 2012-07-26 | ||
PCT/EP2013/065736 WO2014016381A1 (en) | 2012-07-26 | 2013-07-25 | CRYSTALLINE COMPLEX OF 1-CYANO-2-(4-CYCLOPROPYL-BENZYL)-4-(ß- D-GLUCOPYRANOS-1-YL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201500574QA true SG11201500574QA (en) | 2015-02-27 |
Family
ID=48874313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201500574QA SG11201500574QA (en) | 2012-07-26 | 2013-07-25 | CRYSTALLINE COMPLEX OF 1-CYANO-2-(4-CYCLOPROPYL-BENZYL)-4-(ß- D-GLUCOPYRANOS-1-YL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
Country Status (23)
Country | Link |
---|---|
US (1) | US9145434B2 (en) |
EP (3) | EP3351539B1 (en) |
JP (2) | JP6538556B2 (en) |
CN (2) | CN104470908A (en) |
AR (1) | AR091908A1 (en) |
AU (1) | AU2013294947B2 (en) |
BR (1) | BR112015001327B1 (en) |
CA (1) | CA2878698C (en) |
DK (2) | DK2877460T3 (en) |
EA (2) | EA201600506A1 (en) |
ES (2) | ES2694675T3 (en) |
FI (1) | FI3351539T3 (en) |
HR (2) | HRP20230081T1 (en) |
HU (1) | HUE061450T2 (en) |
LT (1) | LT3351539T (en) |
MX (1) | MX357906B (en) |
PL (2) | PL2877460T3 (en) |
PT (2) | PT3351539T (en) |
RS (1) | RS63881B1 (en) |
SG (1) | SG11201500574QA (en) |
SI (2) | SI2877460T1 (en) |
TW (1) | TW201418275A (en) |
WO (1) | WO2014016381A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9145434B2 (en) | 2012-07-26 | 2015-09-29 | Boehringer Ingelheim International Gmbh | Crystalline complex of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss-d-glucopyranos-1-yl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
PL2981269T3 (en) | 2013-04-04 | 2024-02-05 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
HUE053906T2 (en) | 2013-12-17 | 2021-07-28 | Boehringer Ingelheim Vetmedica Gmbh | Sglt2 inhibitors for the treatment of metabolic disorders in feline animals |
US10603300B2 (en) * | 2014-01-23 | 2020-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in canine animals |
PT3125882T (en) | 2014-04-01 | 2020-08-17 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
CN103965020B (en) * | 2014-05-06 | 2015-09-09 | 启东东岳药业有限公司 | Prepare the method for 5-iodo-2-bromobenzyl alcohol |
KR102539788B1 (en) | 2014-09-25 | 2023-06-07 | 베링거잉겔하임베트메디카게엠베하 | Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals |
HUE052588T2 (en) * | 2014-09-30 | 2021-05-28 | Jiangsu Hengrui Medicine Co | Crystal of a complex of l-proline/sodium-glucose cotransporter 2 inhibitor |
CZ2015110A3 (en) * | 2015-02-18 | 2016-08-31 | Zentiva, K.S. | Empagliflozin solid forms |
CN107995862B8 (en) | 2015-08-27 | 2021-12-03 | 勃林格殷格翰维特梅迪卡有限公司 | Liquid pharmaceutical composition comprising SGLT-2 inhibitor |
WO2017203457A1 (en) * | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratories Limited | Solid state forms of empagliflozin |
WO2017206827A1 (en) | 2016-05-28 | 2017-12-07 | 山东轩竹医药科技有限公司 | Crystal form of sodium-glucose cotransporter 2 inhibitor |
CA3085671A1 (en) | 2017-12-19 | 2019-06-27 | Boehringer Ingelheim Vetmedica Gmbh | Synthesis of the 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(beta-d-glucopyranos-1 -yl)-benzene, l-proline and water |
EP4064854A1 (en) | 2019-11-28 | 2022-10-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors in the drying-off of non-human mammals |
EP4106744A1 (en) | 2020-02-17 | 2022-12-28 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines |
EP4376830A1 (en) | 2021-07-28 | 2024-06-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors for the prevention and/or treatment of renal diseases in non-human mammals |
WO2023006718A1 (en) | 2021-07-28 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Use of sglt-2 inhibitors for the prevention and/or treatment of cardiac diseases in non-human mammals excluding felines, in particular canines |
WO2023006745A1 (en) | 2021-07-28 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Use of sglt-2 inhibitors for the prevention and/or treatment of hypertension in non-human mammals |
WO2023227492A1 (en) | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2258141T3 (en) * | 2001-04-11 | 2006-08-16 | Bristol-Myers Squibb Company | C-ARILO GLUCOSIDE AMINO ACIDS COMPLEX FOR DIABETES TREATMENT AND PROCEDURE. |
US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
US7375213B2 (en) * | 2003-01-03 | 2008-05-20 | Bristol-Myers Squibb Company | Methods of producing C-aryl glucoside SGLT2 inhibitors |
CA2557801C (en) * | 2004-03-16 | 2013-06-25 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
EP1926720B1 (en) * | 2005-09-08 | 2010-12-15 | Boehringer Ingelheim International GmbH | CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
AR059489A1 (en) | 2006-02-15 | 2008-04-09 | Boehringer Ingelheim Vetmed | BENZONITRILE DERIVATIVES REPLACED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, USE AND PROCEDURE FOR MANUFACTURING |
TWI370818B (en) * | 2006-04-05 | 2012-08-21 | Astellas Pharma Inc | Cocrystal of c-glycoside derivative and l-proline |
PE20080697A1 (en) * | 2006-05-03 | 2008-08-05 | Boehringer Ingelheim Int | BENZONITRILE DERIVATIVES SUBSTITUTED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, THEIR USE AND PROCEDURE FOR THEIR MANUFACTURE |
US7919598B2 (en) | 2006-06-28 | 2011-04-05 | Bristol-Myers Squibb Company | Crystal structures of SGLT2 inhibitors and processes for preparing same |
TW200817424A (en) | 2006-08-04 | 2008-04-16 | Daiichi Sankyo Co Ltd | Benzylphenyl glucopyranoside derivatives |
AR065809A1 (en) | 2007-03-22 | 2009-07-01 | Bristol Myers Squibb Co | PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR |
WO2008144346A2 (en) * | 2007-05-18 | 2008-11-27 | Bristol-Myers Squibb Company | Crystal structures of sglt2 inhibitors and processes for their preparation |
CN103319445B (en) * | 2007-12-27 | 2016-01-20 | 阿斯利康公司 | Crystalline structure of SGLT2 inhibitor and preparation method thereof |
NZ591818A (en) * | 2008-08-22 | 2013-01-25 | Theracos Inc | Processes for the preparation of sglt2 inhibitors |
JP4825322B1 (en) | 2008-08-28 | 2011-11-30 | ファイザー・インク | Dioxa-bicyclo [3.2.1] octane-2,3,4-triol derivative |
US20100167988A1 (en) | 2008-10-22 | 2010-07-01 | Auspex Pharmaceuticals, Inc. | Ethoxyphenylmethyl inhibitors of sglt2 |
WO2011153712A1 (en) * | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
US9145434B2 (en) | 2012-07-26 | 2015-09-29 | Boehringer Ingelheim International Gmbh | Crystalline complex of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss-d-glucopyranos-1-yl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
PL2981269T3 (en) | 2013-04-04 | 2024-02-05 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
-
2013
- 2013-07-23 US US13/948,751 patent/US9145434B2/en active Active
- 2013-07-25 ES ES13740309.3T patent/ES2694675T3/en active Active
- 2013-07-25 PT PT181550799T patent/PT3351539T/en unknown
- 2013-07-25 ES ES18155079T patent/ES2937665T3/en active Active
- 2013-07-25 EA EA201600506A patent/EA201600506A1/en unknown
- 2013-07-25 PL PL13740309T patent/PL2877460T3/en unknown
- 2013-07-25 EP EP18155079.9A patent/EP3351539B1/en active Active
- 2013-07-25 WO PCT/EP2013/065736 patent/WO2014016381A1/en active Application Filing
- 2013-07-25 DK DK13740309.3T patent/DK2877460T3/en active
- 2013-07-25 JP JP2015523552A patent/JP6538556B2/en active Active
- 2013-07-25 LT LTEP18155079.9T patent/LT3351539T/en unknown
- 2013-07-25 AR ARP130102660A patent/AR091908A1/en unknown
- 2013-07-25 PT PT13740309T patent/PT2877460T/en unknown
- 2013-07-25 SI SI201331237T patent/SI2877460T1/en unknown
- 2013-07-25 EP EP22202153.7A patent/EP4166548A1/en active Pending
- 2013-07-25 CN CN201380037186.1A patent/CN104470908A/en active Pending
- 2013-07-25 MX MX2015000962A patent/MX357906B/en active IP Right Grant
- 2013-07-25 AU AU2013294947A patent/AU2013294947B2/en active Active
- 2013-07-25 DK DK18155079.9T patent/DK3351539T3/en active
- 2013-07-25 CA CA2878698A patent/CA2878698C/en active Active
- 2013-07-25 RS RS20230025A patent/RS63881B1/en unknown
- 2013-07-25 HU HUE18155079A patent/HUE061450T2/en unknown
- 2013-07-25 CN CN201810468431.9A patent/CN108774200A/en active Pending
- 2013-07-25 PL PL18155079.9T patent/PL3351539T3/en unknown
- 2013-07-25 HR HRP20230081TT patent/HRP20230081T1/en unknown
- 2013-07-25 SI SI201332031T patent/SI3351539T1/en unknown
- 2013-07-25 EP EP13740309.3A patent/EP2877460B1/en active Active
- 2013-07-25 BR BR112015001327-9A patent/BR112015001327B1/en active IP Right Grant
- 2013-07-25 SG SG11201500574QA patent/SG11201500574QA/en unknown
- 2013-07-25 EA EA201500038A patent/EA025438B1/en not_active IP Right Cessation
- 2013-07-25 TW TW102126724A patent/TW201418275A/en unknown
-
2018
- 2018-05-08 JP JP2018089968A patent/JP2018135384A/en active Pending
- 2018-11-23 HR HRP20181972TT patent/HRP20181972T1/en unknown
-
2022
- 2022-07-25 FI FIEP18155079.9T patent/FI3351539T3/en active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181972T1 (en) | CRYSTALLINE COMPLEX OF 1-CYANO-2-(4-CYCLOPROPYL-BENZYL)-4-(ß- D-GLUCOPYRANOS-1-YL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS | |
IL231382A (en) | Benzonitrile derivatives, their preparation and medicaments containing them | |
IL231386A0 (en) | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof | |
HRP20181704T1 (en) | Crystal form of chidamide, preparation method and use thereof | |
PT2687539T (en) | Annexin v variant, and preparation and use thereof | |
EP2933250A4 (en) | Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof | |
EP2742020A4 (en) | N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same | |
EP2881385A4 (en) | Novel azo compound, use thereof and method for preparing same | |
EP2813495A4 (en) | 2-arylbenzofuran-7-formamide compounds, preparation method and use thereof | |
EP2757092A4 (en) | Substituted cyanoaniline compounds, preparation and use thereof | |
EP2924042A4 (en) | Bis- -carboline compound and preparation method, pharmaceutical composition and use thereof | |
HK1211570A1 (en) | Indene derivatives, their preparation and use as medicaments | |
HK1209127A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
HK1204613A1 (en) | Substituted pyrano and furanoquinolines, their preparation and use as medicaments | |
ZA201407214B (en) | Therapeutic preparation and process for preparing said therapeutic preparation | |
SG11201405376TA (en) | CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF | |
EP2924021A4 (en) | Anti-hiv compound and preparation method and use thereof | |
EP2926811A4 (en) | Artemether-containing pharmaceutical composition, preparation, and use thereof | |
PL398021A1 (en) | New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof | |
PL398018A1 (en) | New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof | |
GB201112642D0 (en) | Surgical hair preparation substance |